维普期刊资源整合服务平台（V6.5）

90篇 您的检索式：作者名="Gleave ME"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Introducing the clusterin gene into human renal cell carcinoma cells enhances their metastatic potential 显示文摘	Miyake H Gleave ME Arakawa S	2002	J Urol2002，167，5：	1
2	Intermittent androgen suppression delays progression to androgen-dependent regulation of prostate-specific antigen gene in the LNCaP prostate turnout model显示文摘	Sato N Gleave ME Bruehovsky N	1996	J Steroid Biochem Mol Biol1996，58，2：	1
3	Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report 显示文摘	Bruchovsky N Gleave ME	1995	Urology1995，45，5：	1
4	Insulin receptor expression by human prostate cancers显示文摘	Cox ME Gleave ME Zakikhani M	2009	Prostate2009，69，1：	1
5	Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model显示文摘	Sato N Gleave ME Bruchovsky N	1996	J Steroid Biochem Mol Biol1996，58，2：	1
6	Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model显示文摘	Yamanaka K Gleave ME Hara I	2005	Mol Cancer Ther2005，4，：	1
7	A metastasis and andro-gen-sensitive human prostate cancer modelusing intraprostatic inoculation of LNCaP cells in SCID mice显示文摘	Sato N Gleave ME Bruchovsky N	1997	Cancer Res1997，57，：	1
8	Inhibition of progression to androgen-independence by combined adjuvant treatment with antisense Bcl-xL and antisense Bcl-2 oligonucleotides plus taxol after castration in the shionogi tumor model显示文摘	Miyake H Monia BP Gleave ME	2000	Int J Cancer2000，86，6：	1
9	Androgens and prostate cancer显示文摘	So AI Hurtado-Coll A Gleave ME	2003	World J Urol2003，21，5：	1
10	Antisense therapy for cancer 显示文摘	Gleave ME Monia BP	2005	Nat Rev Cancer2005，，5：	1
11	Use of anti-sense oligonucleotides targeting the antiapoptotic gene, Clus-terin/testosterone - repressed prostate message2 to enhance androgen sensitivity and chemosensitivity in prostate cancer显示文摘	Gleave ME Miyake H Zellweger T	2001	Urology2001，58，21：	1
12	A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice 显示文摘	Sato N Gleave ME Bruchovsky N	1997	Cancer Res1997，57，8：	1
13	Intermittent androgen suppression in the treatment of prostate cancer,A preliminary report显示文摘	Goldenberg SL Bruchovsdy N Gleave ME	1995	Urology1995，45，5：	1
14	Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model 显示文摘	Sato N Gleave ME Bruchovsky N	1996	J-Steroid Biochem Mol Biol1996，58，2：	1
15	Protection of androgen- dependent human prostate cancer cells from oxidative stress- induced DNA damage by overexpression of clusterin and its modulation by androgen显示文摘	Miyake H Hara I Gleave ME	2004	Prostate2004，61，4：	1
16	Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report 显示文摘	Goldenberg SL B ruchovsky N Gleave ME	1995	Urology1995，45，5：	1
17	Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumor model 显示文摘	Sato N Gleave ME Bruchovsky N	1996	J Steroid Biochem Mol Biol1996，58，2：	1
18	Prostate-tumor targeting of gene expressing by lentiviral vectors containing elements of proba- sin promoter显示文摘	Yu D Jia WW Gleave ME	2004	Prostate2004，59，4：	1
19	Derivation of androgen- independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells 显示文摘	Wu HC Hsieh JT Gleave ME	1994	Int J Cancer1994，57，3：	1
20	A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer显示文摘	Gleave ME Klasa R	2001	Clin Cancer Res2001，7，12：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示